https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index en-au 5 Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:18998 Wed 20 May 2020 07:08:07 AEST ]]> Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the primary therapy of early breast cancer 2015 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:22889 Annals of Oncology online.]]> Wed 11 Apr 2018 11:24:51 AEST ]]> Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:21643 Wed 11 Apr 2018 11:01:30 AEST ]]>